PD 0348292 + Enoxaparin
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Thrombosis
Conditions
Venous Thrombosis
Trial Timeline
Mar 1, 2006 → Jul 1, 2007
NCT ID
NCT00306254About PD 0348292 + Enoxaparin
PD 0348292 + Enoxaparin is a phase 2 stage product being developed by Pfizer for Venous Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00306254. Target conditions include Venous Thrombosis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00306254 | Phase 2 | Completed |
Competing Products
20 competing products in Venous Thrombosis